APRINOIA THERAPEUTICS

aprinoia-therapeutics-logo

APRINOIA is a late-stage biotechnology company committed to protecting patients' brain health and changing outcomes of neurodegenerative diseases through first-in-class and best-in-class diagnostic tools and novel therapies. The company aims to bring precision medicine to neuroscience by identifying and targeting the protein aggregates of tau, alpha-synuclein and other proteins that play a critical role in the pathogenesis of many neurodegenerative diseases, such as Alzheimer's and Parkinson's Diseases. The company currently has operations in Hong Kong, Suzhou, Shanghai, Tokyo, and Boston.

#SimilarOrganizations #People #Financial #Website #More

APRINOIA THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Diagnostics Medical Therapeutics

Founded:
2015-05-20

Address:
Hong Kong, Hong Kong Island, Hong Kong

Country:
Hong Kong

Website Url:
http://www.aprinoia.com

Total Employee:
51+

Status:
Active

Contact:
+1-617-225-4415

Email Addresses:
[email protected]

Total Funding:
57.53 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

disarm-therapeutics-logo

Disarm Therapeutics

Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.


Current Advisors List

walter-h-moos_image

Walter H. Moos Board Director @ APRINOIA Therapeutics
Board_member
2018-03-29

not_available_image

Narita Hiroki Board Director @ APRINOIA Therapeutics
Board_member
2017-02-09

ming-kuei-jang_image

Ming-Kuei Jang Chairman @ APRINOIA Therapeutics
Board_member
2015-05-20

not_available_image

Kevin Kuk-Hyun Kyung Board Director @ APRINOIA Therapeutics
Board_member
2017-09-01

paul-tempest_image

Paul Tempest Board Director @ APRINOIA Therapeutics
Board_member
2017-02-09

not_available_image

Zhigang Luo Board Director @ APRINOIA Therapeutics
Board_member
2021-06-08

tzu-chen-yen_image

Tzu-Chen Yen Board Director @ APRINOIA Therapeutics
Board_member
2017-06-01

Current Employees Featured

ming-kuei-jang_image

Ming-Kuei Jang
Ming-Kuei Jang Cofounder & CEO @ APRINOIA Therapeutics
Cofounder & CEO
2015-02-01

bradford-navia_image

Bradford Navia
Bradford Navia Chief Medical Officer and Executive Vice President @ APRINOIA Therapeutics
Chief Medical Officer and Executive Vice President

paul-tempest_image

Paul Tempest
Paul Tempest Head of Medicinal Chemistry and Senior Vice President @ APRINOIA Therapeutics
Head of Medicinal Chemistry and Senior Vice President
2015-10-01

chin-yin-tai_image

Chin-Yin Tai
Chin-Yin Tai Vice President of Neurobiology @ APRINOIA Therapeutics
Vice President of Neurobiology

masaomi-miyamoto_image

Masaomi Miyamoto
Masaomi Miyamoto Executive Vice President of R&D and Operations @ APRINOIA Therapeutics
Executive Vice President of R&D and Operations

tzu-chen-yen_image

Tzu-Chen Yen
Tzu-Chen Yen General Manager @ APRINOIA Therapeutics
General Manager

sanjay-sehgal_image

Sanjay Sehgal
Sanjay Sehgal Senior Vice President & Global Head of Regulatory Affairs @ APRINOIA Therapeutics
Senior Vice President & Global Head of Regulatory Affairs

lili-zhang_image

Lili Zhang
Lili Zhang Senior Vice President, Head of Preclinical Development @ APRINOIA Therapeutics
Senior Vice President, Head of Preclinical Development

Founder


ming-kuei-jang_image

Ming-Kuei Jang

Investors List

imm-private-equity_image

IMM Private Equity

IMM Private Equity investment in Series C - APRINOIA Therapeutics

ktb-network-2_image

KTB Network

KTB Network investment in Series C - APRINOIA Therapeutics

yantai-dongcheng-pharmaceutical_image

Yantai Dongcheng Pharmaceutical

Yantai Dongcheng Pharmaceutical investment in Series C - APRINOIA Therapeutics

ktb-network-2_image

KTB Network

KTB Network investment in Series B - APRINOIA Therapeutics

dci-partners_image

DCI Partners

DCI Partners investment in Series B - APRINOIA Therapeutics

taian-technologies_image

TaiAn Technologies

TaiAn Technologies investment in Series B - APRINOIA Therapeutics

shangpharma_image

ShangPharma

ShangPharma investment in Series B - APRINOIA Therapeutics

Official Site Inspections

http://www.aprinoia.com Semrush global rank: 6.79 M Semrush visits lastest month: 788

  • Host name: cloudproxy10054.sucuri.net
  • IP address: 192.124.249.54
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "APRINOIA Therapeutics" on Search Engine